UBS Group’s ENVUE MEDICAL INC NEW FEED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2
Closed -$57 10830
2026
Q1
$57 Sell
2
-3
-60% -$78 ﹤0.01% 10190
2025
Q4
$139 Buy
5
+2
+67% +$113 ﹤0.01% 10151
2025
Q3
$198 Sell
3
-111
-97% -$10K ﹤0.01% 9817
2025
Q2
$12.7K Buy
114
+71
+165% +$25.4K ﹤0.01% 8727
2025
Q1
$17.6K Buy
43
+12
+39% +$6.61K ﹤0.01% 8314
2024
Q4
$24.3K Buy
31
+30
+3,000% +$24.3K ﹤0.01% 7751
2024
Q3
$910 Buy
+1
New +$873 ﹤0.01% 8781
2024
Q2
Hold
0
9268
2024
Q1
Sell
-3
Closed -$4.07K 9789
2023
Q4
$4.07K Sell
3
-4
-57% -$5.89K ﹤0.01% 7905
2023
Q3
$17.5K Buy
+7
New +$25K ﹤0.01% 6878
2023
Q2
Sell
-3
Closed -$12.6K 9394
2023
Q1
$12.6K Buy
+3
New +$19.4K ﹤0.01% 7436
2022
Q4
Sell
-1
Closed -$9.88K 9699
2022
Q3
$13K Buy
+1
New +$15.6K ﹤0.01% 8050
2022
Q2
Hold
0
-$4K 10703
2022
Q1
Hold
0
9303
2021
Q4
Hold
0
9044
2021
Q3
Sell
-1
Closed -$22K 9879
2021
Q2
$22K Sell
1
-1
-50% -$24.3K ﹤0.01% 7237
2021
Q1
$56K Buy
+2
New +$61.5K ﹤0.01% 6429
2020
Q4
Hold
0
7628
2020
Q2
Hold
0
-$5K 8207
2020
Q1
Hold
0
7305
2019
Q4
Hold
0
7963
2019
Q3
Hold
0
-$1K 8155
2019
Q2
Hold
0
7724
2019
Q1
Hold
0
-$16K 8001
2018
Q4
Hold
0
6945
2018
Q3
Hold
0
6796
2018
Q2
Hold
0
7036
2018
Q1
Hold
0
6618
2017
Q4
Hold
0
7026

Other funds holding FEED

UBS Group's FEED Position: Q2 2026 in Review

UBS Group sold out of ENVUE MEDICAL INC NEW (FEED) in Q2 2026, closing a stake of 2 shares — an estimated $57 sold.

UBS Group first reported a position in FEED in Q1 2021 and held it in 13 quarters. The position peaked at $56K in Q1 2021. 12 funds tracked by Wall St. Rank hold FEED as of Q2 2026.

  • UBS Group reported no remaining ENVUE MEDICAL INC NEW position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 2 ENVUE MEDICAL INC NEW shares in Q2 2026, an estimated $57.
  • UBS Group first reported a position in ENVUE MEDICAL INC NEW in Q1 2021 and held it in 13 quarters.
  • UBS Group's ENVUE MEDICAL INC NEW position peaked at $56K in Q1 2021.
  • 12 funds tracked by Wall St. Rank held ENVUE MEDICAL INC NEW as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.